Project Scope |
This project team will define best practices for ensuring that similar types of adverse events are considered together for purposes of safety analyses. This project will develop efficient standardised processes and analyses that can leverage new technologies. |
| Project Leads | Emails | |
|---|---|---|
| Mary Nilsson | nilsson_mary_e@lillyMac Gordon, Johnson & Johnson | |
| Greg Ball | gball@novavaxPeg Fletcher, MedAssessment | peg.fletcher@medassessment.com |
| Objectives & Deliverables | ||
| White Paper | ||
| Journal Article | ||
| Nicola Newton, PHUSE Project Assistant |
| Vaishali Popat | FDA
| ||||||
|---|---|---|---|---|---|---|---|
| New project for Q22022 | |||||||
| Project Members | Organisation | ||||||
| Nhi Beasley | FDA | ||||||
| Rebeka Revis | IQVIA | ||||||
| Scott Proestel | FDA | ||||||
Q3 2024 | |||||||
|
| Objectives & Deliverables | Timelines |
|---|---|
| Complete White Paper final draft | Q2 2023 |